Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/UK EMC/Rennie Dual Action Chewable Tablets

Approved

STANDARD

Rennie Dual Action Chewable Tablets

Bayer plc🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 6c8f59b5b9ecac4c
Company: Bayer plc
Type: Standard

Approval Details

Approval Id: 6c8f59b5b9ecac4c
Drug Approval Emc Name: Rennie Dual Action Chewable Tablets
Drug Name: Rennie Dual Action Chewable Tablets
Company Name: Bayer plc
Company Address: 400 South Oak Way, Reading, Berkshire, RG2 6AD
Company Website: http://www.bayer.co.uk
Company Telephone: +44 (0)118 206 3000
Company Medical Info Email: medical.information@bayer.co.uk
Atc Code: A02AX
Legal Category: General Sales List

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

6c8f59b5b9ecac4c

Type

Standard

Back to UK EMC Approvals

Rennie Dual Action Chewable Tablets - UK EMC Drug Approval Details